InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,517.20
(
0.53%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
73.12
(
-0.10%
)
Bitcoin
63,079.33
(
-0.09%
)
Post# of 253225
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Mufaso

Send PM Follow Ignore
Followers 37
Posts 552
Boards Moderated 0
Alias Born 01/08/2008

Mufaso

Member Level

Re: rfj1862 post# 246934

Tuesday, 05/16/2023 8:18:05 AM

Tuesday, May 16, 2023 8:18:05 AM

Post# of 253225
VKTX- Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)

https://ir.vikingtherapeutics.com/2023-05-16-Viking-Therapeutics-Announces-Positive-Top-Line-Results-from-Phase-2b-VOYAGE-Study-of-VK2809-in-Patients-with-Biopsy-Confirmed-Non-Alcoholic-Steatohepatitis-NASH

Good call on timing of data release!

Results look very good- especially safety vs placebo
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up